NEW YORK (Reuters Health) - Middle-aged men who take aspirin or other "nonsteroidal anti-inflammatory drug" (NSAID) have significantly lower levels of a blood protein used to spot prostate cancer than ...
LONDON (Reuters) - A popular baldness drug taken by more than 4 million men worldwide can mask an important marker used in screening tests to detect prostate cancer, scientists said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback